Search Results
Viewing: 71-80 of 86 | All
News
Wexner Completes Seven Transformative Years as Nationwide Childrens Board Chair; Fischer Succeeds
After seven years as board chair of Nationwide Children’s Hospital Inc. and Nationwide Children’s Hospital – leading a period of unprecedented growth and success– Abigail Wexner stepped down as chair effective August 24.

Specialty
Epilepsy Surgery
Epilepsy Surgery services at Nationwide Children’s involves a team of specialists to care for the clinical, surgical and psychosocial needs of children with difficult to control epilepsy. Epilepsy surgery may dramatically improve the quality of life for these children and is the only potential cure.
News
#ChildrensHospitalsWeek Announced for March 20-27, 2017
SALT LAKE CITY [February 28, 2017] – To shine a light on the importance of children’s hospitals and how donations help kids get the best care when they need it, Children’s Miracle Network Hospitals (CMN Hospitals) is announcing the first #ChildrensHospitalsWeek, scheduled for

Article
Research Faculty Careers
The Abigail Wexner Research Institute (AWRI) at Nationwide Children’s is ranked among the top 10 freestanding children’s hospitals based on NIH funding. On a continuing trajectory of rapid growth, AWRI is looking for new faculty to drive the next generation of discovery at Nationwide Children's.

Specialty
Steve and Cindy Rasmussen Institute for Genomic Medicine
The Steve and Cindy Rasmussen Institute for Genomic Medicine combines a robust clinical laboratory with genome scientists and clinical geneticists to optimize patient care.
Article
Peds-ONC Immunotherapy Center
The Pediatric Ohio-New York Cancer (Peds-ONC) Immunotherapy Center’s overarching hypothesis is that, in addition to adaptive immunotherapies, innate immune mechanisms of resistance in pediatric cancers can be leveraged as cancer immunotherapeutics.

Funding
ASPIRES funds small-scale, innovative, exploratory research to advance youth suicide prevention. Generating promising pilot data can enable researchers to apply for the funding necessary to conduct larger studies.
Article
Fontanella Lab Staff
Learn more about principal investigator Cynthia Fontanella, PhD, and her dynamic team in the Fontanella Lab.
News
Study supports virotherapy as a potential treatment for brain tumors
A new study provides additional evidence of the efficacy of virotherapy for glioblastoma, the most deadly type of brain tumor. The research findings, published Feb. 1, 2022, in Clinical Cancer Research, indicate that an oncolytic herpes simplex virus, G207, appears to boost immune response and that this is associated with better overall survival for patients with glioblastoma.